Home
Scholarly Works
Clinical and pharmacokinetic (PK) results of 4...
Conference

Clinical and pharmacokinetic (PK) results of 4 phase I studies of the second generation matrix metalloprotease (MMP) inhibitor Bay 12-9566, a non-peptidic biphenyl inhibitor of MMPs 2, 3&9

Authors

Seymour L; Grochow L; Eckhardt G; Erlichman C; Hirte H; Goel R; Humphrey R; Elias I

Volume

9

Pagination

pp. 125-125

Publisher

KLUWER ACADEMIC PUBL

Publication Date

January 1, 1998

Conference proceedings

ANNALS OF ONCOLOGY

ISSN

0923-7534

Contact the Experts team